• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Insite Vision Inc

+ Add to Watchlist


0.3050 USD 0.0125 3.94%

As of 13:07:43 ET on 09/19/2014.

Snapshot for Insite Vision Inc (INSV)

Open: 0.3175 Day's Range: 0.3050 - 0.3175 Volume: 7,572
Previous Close: 0.3175 52wk Range: 0.1000 - 0.3600 1-Yr Rtn: +56.41%

Stock Chart for INSV

No chart data available.
  • INSV:US 0.3050
  • 1D
  • 1M
  • 1Y
Interactive INSV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSV

Current P/E Ratio (ttm) 11.1363
Estimated P/E(12/2014) 1.6944
Relative P/E vs. SPX 0.6128
Earnings Per Share (USD) (ttm) 0.0274
Est. EPS (USD) (12/2014) 0.1800
Est. PEG Ratio -
Market Cap (M USD) 40.25
Shares Outstanding (M) 131.95
30 Day Average Volume 73,694
Price/Book (mrq) -
Price/Sale (ttm) 2.9112
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSV

InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.

Timothy M RuaneChief Executive OfficerKamran HosseiniChief Medical Officer
Louis C DrapeauVP/CFOLyle M BowmanVP:Development/Secretary
More Company Profile & Key Executives for INSV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • INSV News

  • Industry News

Sponsored Links
sec ||= nil